Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells

NCT01173510 is registered in ClinicalTrials.gov with Community Research Initiative of New England as lead sponsor.

NCT NCT01173510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01173510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
Lead sponsor
Community Research Initiative of New England
Phase
Phase 4
Overall status
Withdrawn
Start date
August 23, 2010
Completion date
October 19, 2012
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immune deficiency syndrome, hiv infections